Enanta Pharmaceuticals ENTA
NASDAQ ENTA
$12.99 +0.35 (+2.77%)
As of: Sep 30, 2026 · 10:25 AM EDT

Enanta Pharmaceuticals (ENTA) Net Margin (2012 - 2026)

Updated

Enanta Pharmaceuticals (ENTA) posted Net Margin of -135.81% for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 36.13 percentage points from -99.68% a year earlier and down 59.52 percentage points from the prior quarter.

Analysis

Enanta Pharmaceuticals (ENTA) Net Margin (2012 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Net Margin at Enanta Pharmaceuticals was -96.89%, up 45.09 percentage points year-over-year; for FY2025 (ended Sep 30, 2025), it came in at -125.36%, up 46.22 percentage points from FY2024.

  • Annual Net Margin shows a five-year change of -95.83 percentage points (FY2020 to FY2025).
  • In prior fiscal years, Enanta Pharmaceuticals' Net Margin was -171.58% in FY2024 (-2.62 pp), -168.95% in FY2023 (-27.64 pp), -141.31% in FY2022 (-59.94 pp) and -81.38% in FY2021 (-51.85 pp).
  • The fiscal Q3 2026 figure stands as the lowest quarterly Net Margin since fiscal Q2 2025.
  • On a year-over-year basis, Net Margin increased in six of the last eight quarters, with an average year-over-year change of +30.37 percentage points.
  • The strongest year-over-year quarter for Net Margin in the past five years was fiscal Q3 2024, with a gain of 80.70 percentage points; the weakest was fiscal Q1 2022, with a drop of 82.69 percentage points.
  • According to Business Quant data, Net Margin for the three prior fiscal quarters was -76.29% (Q2 2026), -64.13% (Q1 2026) and -123.64% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 21.86%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 21.27%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -8.04%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 22.61%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 18.81%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 23.62%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -134.51%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -1.65%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 32.99%
10 Enanta Pharmaceuticals 367.20 Mn -360.79 Mn - -135.81%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -135.81%
Mar 31, 2026 -76.29%
Dec 31, 2025 -64.13%
Sep 30, 2025 -123.64%
Jun 30, 2025 -99.68%
Mar 31, 2025 -151.71%
Dec 31, 2024 -131.43%
Sep 30, 2024 -197.32%
Jun 30, 2024 -126.08%
Mar 31, 2024 -182.70%
Dec 31, 2023 -185.56%
Sep 30, 2023 -148.46%
Jun 30, 2023 -206.78%
Mar 31, 2023 -211.62%
Dec 31, 2022 -122.90%
Sep 30, 2022 -129.68%
Jun 30, 2022 -162.74%
Mar 31, 2022 -179.48%
Dec 31, 2021 -108.92%
Sep 30, 2021 -104.34%
API Access

Enanta Pharmaceuticals Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=ENTA&period=max&api_key=YOUR_API_KEY